Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Reagent

HEALTH-CORONAVIRUS/ITALY
RTX8AAZ8
November 18, 2020
A medical worker wearing protective clothing holds a vial with reagents in the coronavirus disease (COVID-19)...
Naples, Italy
Outbreak of the coronavirus disease (COVID-19), in Naples
A medical worker wearing protective clothing holds a vial with reagents in the coronavirus disease (COVID-19) testing centre at San Severo fuori le mura church, in Naples, Italy November 18, 2020. REUTERS/Ciro De Luca
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTX81XEQ
October 13, 2020
A biologist shows a EasyCOV rapid salivary test which displays yellow reagent positive at the Covid-19...
Paris, France
French firm develops saliva test for COVID-19
A biologist shows a EasyCOV rapid salivary test which displays yellow reagent positive at the Covid-19 disease, in Paris, France, October 12, 2020. Picture taken October 12, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/ANTIGEN-TEST
RTX80UTO
October 08, 2020
Reagents used in the BOSCH Vivalytic SARS-CoV-2 test, produced by R-Biopharm, are pictured in the production...
PFUNGSTADT, Germany
R-Biopharm presents SARS-CoV-2 rapid antigen test
Reagents used in the BOSCH Vivalytic SARS-CoV-2 test, produced by R-Biopharm, are pictured in the production plant of diagnostics provider R-Biopharm in Pfungstadt near Darmstadt, Germany October 8, 2020. REUTERS/Ralph Orlowski
HEALTH-CORONAVIRUS/ANTIGEN-TEST
RTX80UTN
October 08, 2020
Reagents used in the BOSCH Vivalytic SARS-CoV-2 test, produced by R-Biopharm, are pictured in the production...
PFUNGSTADT, Germany
R-Biopharm presents SARS-CoV-2 rapid antigen test
Reagents used in the BOSCH Vivalytic SARS-CoV-2 test, produced by R-Biopharm, are pictured in the production plant of diagnostics provider R-Biopharm in Pfungstadt near Darmstadt, Germany October 8, 2020. REUTERS/Ralph Orlowski
HEALTH-CORONAVIRUS/ANTIGEN-TEST
RTX80UJE
October 08, 2020
Reagents of a rapid antigen test to detect the SARS-CoV-2 antigen of the diagnostics provider R-Biopharm...
PFUNGSTADT, Germany
R-Biopharm presents SARS-CoV-2 rapid antigen test
Reagents of a rapid antigen test to detect the SARS-CoV-2 antigen of the diagnostics provider R-Biopharm is pictured at their laboratory in Pfungstadt near Darmstadt, Germany October 8, 2020. REUTERS/Ralph Orlowski
HEALTH-CORONAVIRUS/ANTIGEN-TEST
RTX80UJD
October 08, 2020
Reagents of a rapid antigen test to detect the SARS-CoV-2 antigen of the diagnostics provider R-Biopharm...
PFUNGSTADT, Germany
R-Biopharm presents SARS-CoV-2 rapid antigen test
Reagents of a rapid antigen test to detect the SARS-CoV-2 antigen of the diagnostics provider R-Biopharm is pictured at their laboratory in Pfungstadt near Darmstadt, Germany October 8, 2020. REUTERS/Ralph Orlowski
HEALTH-CORONAVIRUS/ANTIGEN-TEST
RTX80UJC
October 08, 2020
Reagents of a rapid antigen test to detect the SARS-CoV-2 antigen of the diagnostics provider R-Biopharm...
PFUNGSTADT, Germany
R-Biopharm presents SARS-CoV-2 rapid antigen test
Reagents of a rapid antigen test to detect the SARS-CoV-2 antigen of the diagnostics provider R-Biopharm is pictured at their laboratory in Pfungstadt near Darmstadt, Germany October 8, 2020. REUTERS/Ralph Orlowski
HEALTH-CORONAVIRUS/ANTIGEN-TEST
RTX80UI2
October 08, 2020
Reagents of a rapid antigen test to detect the SARS-CoV-2 antigen of the diagnostics provider R-Biopharm...
PFUNGSTADT, Germany
R-Biopharm presents SARS-CoV-2 rapid antigen test
Reagents of a rapid antigen test to detect the SARS-CoV-2 antigen of the diagnostics provider R-Biopharm is pictured at their laboratory in Pfungstadt near Darmstadt, Germany October 8, 2020. REUTERS/Ralph Orlowski
HEALTH-CORONAVIRUS/BELGIUM-TESTING
RTX7PABT
August 13, 2020
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective...
Liege, Belgium
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege is seen during a demonstration...
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective suit during a demonstration for the media, showing the production of RNA extraction reagents that will be used on an automated test for the detection of COVID-19, in Liege, Belgium August 12, 2020. According to the university, the test allows thousands of additional tests to be performed every day. Picture taken August 12, 2020. REUTERS/Yves Herman
HEALTH-CORONAVIRUS/BELGIUM-TESTING
RTX7PABP
August 13, 2020
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective...
Liege, Belgium
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege is seen during a demonstration...
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective suit during a demonstration for the media, showing the production of RNA extraction reagents that will be used on an automated test for the detection of COVID-19, in Liege, Belgium August 12, 2020. According to the university, the test allows thousands of additional tests to be performed every day. Picture taken August 12, 2020. REUTERS/Yves Herman
HEALTH-CORONAVIRUS/BELGIUM-TESTING
RTX7PABO
August 13, 2020
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective...
Liege, Belgium
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege is seen during a demonstration...
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective suit during a demonstration for the media, showing the production of RNA extraction reagents that will be used on an automated test for the detection of COVID-19, in Liege, Belgium August 12, 2020. According to the university, the test allows thousands of additional tests to be performed every day. Picture taken August 12, 2020. REUTERS/Yves Herman
HEALTH-CORONAVIRUS/BELGIUM-TESTING
RTX7PABL
August 13, 2020
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective...
Liege, Belgium
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege is seen during a demonstration...
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective suit during a demonstration for the media, showing the production of RNA extraction reagents that will be used on an automated test for the detection of COVID-19, in Liege, Belgium August 12, 2020. According to the university, the test allows thousands of additional tests to be performed every day. Picture taken August 12, 2020. REUTERS/Yves Herman
HEALTH-CORONAVIRUS/BELGIUM-TESTING
RTX7PABI
August 13, 2020
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective...
Liege, Belgium
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege is seen during a demonstration...
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective suit during a demonstration for the media, showing the production of RNA extraction reagents that will be used on an automated test for the detection of COVID-19, in Liege, Belgium August 12, 2020. According to the university, the test allows thousands of additional tests to be performed every day. Picture taken August 12, 2020. REUTERS/Yves Herman
HEALTH-CORONAVIRUS/BELGIUM-TESTING
RTX7PABG
August 13, 2020
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective...
Liege, Belgium
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege is seen during a demonstration...
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective suit during a demonstration for the media, showing the production of RNA extraction reagents that will be used on an automated test for the detection of COVID-19, in Liege, Belgium August 12, 2020. According to the university, the test allows thousands of additional tests to be performed every day. Picture taken August 12, 2020. REUTERS/Yves Herman
HEALTH-CORONAVIRUS/BELGIUM-TESTING
RTX7PAB6
August 13, 2020
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective...
Liege, Belgium
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege is seen during a demonstration...
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective suit during a demonstration for the media, showing the production of RNA extraction reagents that will be used on an automated test for the detection of COVID-19, in Liege, Belgium August 12, 2020. According to the university, the test allows thousands of additional tests to be performed every day. Picture taken August 12, 2020. REUTERS/Yves Herman
HEALTH-CORONAVIRUS/BELGIUM-TESTING
RTX7PAB9
August 13, 2020
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective...
Liege, Belgium
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege is seen during a demonstration...
Jerome Bodart, PhD student at the Greenmat laboratory of the University of Liege, wears a full protective suit during a demonstration for the media, showing the production of RNA extraction reagents that will be used on an automated test for the detection of COVID-19, in Liege, Belgium August 12, 2020. According to the university, the test allows thousands of additional tests to be performed every day. Picture taken August 12, 2020. REUTERS/Yves Herman
HEALTH-CORONAVIRUS/ARGENTINA-TEST
RTX7JN2M
May 19, 2020
Santiago Webajh, scientist of the Pablo Cassara foundation, puts a drop of reagent in a container during...
Buenos Aires, Argentina
Outbreak of the coronavirus disease (COVID-19), in Buenos Aires
Santiago Webajh, scientist of the Pablo Cassara foundation, puts a drop of reagent in a container during a test of the new "NEOKIT-COVID-19?, developed by a group of Argentine scientists that diagnoses the coronavirus disease (COVID-19) in less than two hours, in Buenos Aires, Argentina May 19, 2020. REUTERS/Agustin Marcarian
INDIA-POLLUTION/
RTS2RUVJ
October 19, 2019
A man sprays water, mixed with an ecologically safe reagent, on a road to help precipitation of Suspended...
New Delhi, India
A man sprays water, mixed with an ecologically safe reagent, on a road to help precipitation of Suspended...
A man sprays water, mixed with an ecologically safe reagent, on a road to help precipitation of Suspended Particulate Matter (SPM) near the venue of a half marathon in New Delhi, India October 19, 2019. REUTERS/Anushree Fadnavis
INDIA-POLLUTION/
RTS2RUVH
October 19, 2019
A man sprays water, mixed with an ecologically safe reagent, on a road to help precipitation of Suspended...
New Delhi, India
A man sprays water, mixed with an ecologically safe reagent, on a road to help precipitation of Suspended...
A man sprays water, mixed with an ecologically safe reagent, on a road to help precipitation of Suspended Particulate Matter (SPM) near the venue of a half marathon in New Delhi, India October 19, 2019. REUTERS/Anushree Fadnavis
PERU-HEALTH/
RTSSRLM
November 22, 2016
A health technician analyses blood samples for tuberculosis testing in a high-tech tuberculosis lab in...
Lima, Peru
The Wider Image: Fighting tuberculosis in Peru's village of hope
A health technician analyses blood samples for tuberculosis testing in a high-tech tuberculosis lab in Carabayllo in Lima, Peru May 19, 2016. REUTERS/Mariana Bazo SEARCH "TB HOPE" FOR THIS STORY. SEARCH "THE WIDER IMAGE" FOR ALL STORIES. TPX IMAGES OF THE DAY
HEALTH-BIRDFLU/
RTXY97Q
April 05, 2013
A technician shows the test reagents for the H7 influenza infection (L) and the N9 influenza infection...
Hefei, China
Technician shows test reagents for H7 influenza infection and N9 influenza infection at centre for diseases...
A technician shows the test reagents for the H7 influenza infection (L) and the N9 influenza infection at the centre for diseases control and prevention in Hefei, Anhui province April 5, 2013. Chinese authorities slaughtered over 20,000 birds on Friday at a poultry market in the financial hub Shanghai as the death toll from a new strain of bird flu mounted to six, spreading concern overseas and sparking a sell-off on Hong Kong's share market. REUTERS/Stringer (CHINA - Tags: HEALTH DISASTER ANIMALS)
HEALTH-BIRDFLU/
RTXY97F
April 05, 2013
A technician (not pictured) shows a paper giving the composition and instructions on use of the H7N9...
Hefei, China
Technician) shows paper giving composition and instructions on use of H7N9 bird flu virus test reagent...
A technician (not pictured) shows a paper giving the composition and instructions on use of the H7N9 bird flu virus test reagent at the centre for diseases control and prevention in Hefei, Anhui province April 5, 2013. Chinese authorities slaughtered over 20,000 birds on Friday at a poultry market in the financial hub Shanghai as the death toll from a new strain of bird flu mounted to six, spreading concern overseas and sparking a sell-off on Hong Kong's share market. REUTERS/Stringer (CHINA - Tags: HEALTH DISASTER ANIMALS)
HEALTH-BIRDFLU/
RTXY96E
April 05, 2013
A technician carries out a test on a suspected infected sample using the H7N9 bird flu virus test reagents...
Hefei, China
Technician carries out test on suspected infected sample using H7N9 bird flu virus test reagents at centre...
A technician carries out a test on a suspected infected sample using the H7N9 bird flu virus test reagents at the centre for diseases control and prevention in Hefei, Anhui province April 5, 2013. Chinese authorities were slaughtering birds at a poultry market in the financial hub Shanghai as the death toll from a new strain of bird flu mounted to six on Friday, spreading concern overseas and sparking a sell-off on Hong Kong's share market. According to Xinhua News Agency, east China's Zhejiang Province on Friday morning reported that a man has died from the H7N9 bird flu, bringing the death toll from the new deadly strain to six in the country. REUTERS/Stringer (CHINA - Tags: HEALTH DISASTER ANIMALS)
ADDEX/
RTR215AL
August 15, 2008
An Addex Pharmaceuticals lab technician, observes a reagent at the company headquarters in Plan-les-Ouates...
PLAN-LES-OUATES, Switzerland
An Addex Pharmaceuticals lab technician oberseves a reagent at the company headquarters in Plan-les-Ouates...
An Addex Pharmaceuticals lab technician, observes a reagent at the company headquarters in Plan-les-Ouates near Geneva August 14, 2008. Picture taken August 14, 2008. REUTERS/Denis Balibouse (SWITZERLAND)
CHINA
RTXLWPD
April 08, 2003
Lab workers inside a closed room prepare a reagent for multiplying the viral genes of the Severe Acute...
Hong Kong, China
Lab workers inside a closed room prepare a reagent for multiplying the viral genes of the Severe Acu.....
Lab workers inside a closed room prepare a reagent for multiplying the viral genes of the Severe Acute Respiratory Syndrome (SARS) for further examination at Queen Mary Hospital in Hong Kong April 8, 2003. The deadly virus is putting a massive strain on Hong Kong's health care system as exhausted doctors and nurses battle to cope with a [flood] of new patients and fears that they could become victims themselves. The virus has killed over 100 people and infected more than 2,700 others worldwide.
CHINA
RTXLWPC
April 08, 2003
A lab worker examines a patient's serum, mixed with coronavirus-infected cells and fluorescent reagent,...
Hong Kong, China
A lab worker examines a patient's serum, mixed with coronavirus-infected cells and fluorescent reage.....
A lab worker examines a patient's serum, mixed with coronavirus-infected cells and fluorescent reagent, under the microscope, the final step of one of two diagnostic tests for the Severe Acute Respiratory Syndrome (SARS) designed by the University of Hong Kong, at Queen Mary Hospital in Hong Kong April 8, 2003. The deadly virus is putting a massive strain on Hong Kong's healthcare system as exhausted doctors and nurses battle to cope with a [flood] of new patients and fears that they could become victims themselves.
CHINA
RTXLWPA
April 08, 2003
Lab workers inside a closed room prepare a reagent for multipling the viral genes of the Severe Acute...
Hong Kong, China
Lab workers inside a closed room prepare a reagent for multipling the viral genes of the Severe Acut.....
Lab workers inside a closed room prepare a reagent for multipling the viral genes of the Severe Acute Respiratory Syndrome (SARS) for further examination at Queen Mary Hospital in Hong Kong April 8, 2003. The deadly virus is putting a massive strain on Hong Kong's healthcare system as exhausted doctors and nurses battle to cope with a [flood] of new patients and fears that they could become victims themselves.
HEALTH PNEUMONIA
RTRLJFH
April 08, 2003
A lab worker examines a patient's serum, mixed with
coronavirus-infected cells and fluorescent reagent,...
Hong Kong, China - Peoples Republic of
A LAB WORKER EXAMINES PATIENT'S SERUM UNDER MICROSCOPE IN HONG KONG.
A lab worker examines a patient's serum, mixed with
coronavirus-infected cells and fluorescent reagent, under the
microscope, the final step of one of two diagnostic tests for the
Severe Acute Respiratory Syndrome (SARS) designed by the University of
Hong Kong, at Queen Mary Hospital in Hong Kong April 8, 2003. The
deadly virus is putting a massive strain on Hong Kong's healthcare
system as exhausted doctors and nurses battle to cope with a flood of
new patients and fears that they could become victims themselves.
REUTERS/Bobby Yip

BY/CC
HEALTH PNEUMONIA
RTRLJC9
April 08, 2003
Lab workers inside a closed room prepare a reagent for multipling the
viral genes of the Severe Acute...
Hong Kong, China - Peoples Republic of
LAB WORKERS PREPARE REAGENT TO MULTIPLE VIRAL GENES IN HONG KONG.
Lab workers inside a closed room prepare a reagent for multipling the
viral genes of the Severe Acute Respiratory Syndrome (SARS) for further
examination at Queen Mary Hospital in Hong Kong April 8, 2003. The
deadly virus is putting a massive strain on Hong Kong's healthcare
system as exhausted doctors and nurses battle to cope with a flood of
new patients and fears that they could become victims themselves.
REUTERS/Bobby Yip

BY/CC
HEALTH PNEUMONIA
RTRLJC3
April 08, 2003
Lab workers inside a closed room prepare a reagent for multiplying the
viral genes of the Severe Acute...
Hong Kong, China - Peoples Republic of
LAB WORKERS PREPARE REAGENT TO MULTIPLE VIRAL GENES IN HONG KONG.
Lab workers inside a closed room prepare a reagent for multiplying the
viral genes of the Severe Acute Respiratory Syndrome (SARS) for further
examination at Queen Mary Hospital in Hong Kong April 8, 2003. The
deadly virus is putting a massive strain on Hong Kong's health care
system as exhausted doctors and nurses battle to cope with a flood of
new patients and fears that they could become victims themselves. The
virus has killed over 100 people and infected more than 2,700 others
worldwide. REUTERS/Bobby Yip

BY/CC
IRAQ BRITAIN
RTRKWQE
March 26, 2003
British troops from 42 Commando remove vials containing unspecified
substances labelled 'Poison' and...
Umm Qasr
BRITISH TROOPS REMOVE VIALS FROM SCHOOL IN UMM QASR SOUTHERN IRAQ.
British troops from 42 Commando remove vials containing unspecified
substances labelled 'Poison' and 'Reagent' from a school in Umm Qasr
March 26, 2003. Britain's Prime Minister Tony Blair flew to Washington
on Wednesday for a war council with President George W. Bush, eager to
convince his ally that the United Nations must play a central role in a
post-war Iraq. REUTERS/POOL/Jon Mills

MD/AA
Sort by
Display
Items per page
Page
of 1